WallStreetZenWallStreetZen

NASDAQ: INCY
Incyte Corp Stock Ownership - Who owns Incyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Incyte Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael James MorrisseyEVP Head of Tech. Operations2026-02-02185$102.67
$18.99kSell
Lee HeesonEVP Head of Incyte Intl2026-02-02111$102.67
$11.40kSell
Michael James MorrisseyEVP Head of Tech. Operations2026-01-20429$102.62
$44.02kSell
Mohamed Khairie IssaEVP Head of US Oncology2026-01-0710,856$109.07
$1.18MSell
Mohamed Khairie IssaEVP Head of US Oncology2026-01-068,264$106.66
$881.44kSell
Steven H. SteinEVP Chief Medical Officer2026-01-0515,634$101.70
$1.59MSell
Edmund HarriganDirector2025-12-31245$98.77
$24.20kBuy
Steven H. SteinEVP Chief Medical Officer2025-12-3113,292$98.77
$1.31MSell
Paul J. ClancyDirector2025-12-31241$98.77
$23.80kBuy
Michael James MorrisseyEVP Head of Tech. Operations2025-12-31254$98.77
$25.09kSell

1 of 12

INCY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INCY insiders and whales buy or sell their stock.

INCY Shareholders

What type of owners hold Incyte Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.45%30,743,991$3.11BInstitution
Vanguard Group Inc10.01%19,911,434$2.02BInstitution
Julian Baker9.98%19,851,744$2.01BInsider
Blackrock Inc9.21%18,327,923$1.86BInstitution
Dodge Cox6.66%13,261,742$1.34BInstitution
Baker Brothers Life Sciences LP6.25%12,445,783$1.26BInsider
Baker Brothers Life Sciences Capital GP LLC6.25%12,430,783$1.26BInsider
State Street Corp4.85%9,656,403$978.39MInstitution
Aqr Capital Management LLC3.38%6,720,024$680.87MInstitution
Geode Capital Management LLC2.51%4,993,012$505.89MInstitution

1 of 3

INCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCY77.80%22.20%Net SellingNet Selling
UTHR86.91%13.09%Net SellingNet Selling
MRNA76.86%22.49%Net BuyingNet Buying
RVMD91.20%8.80%Net SellingNet Selling
ROIV43.08%56.92%Net SellingNet Selling
View Top Biotech Stocks

Incyte Stock Ownership FAQ

Who owns Incyte?

Incyte (NASDAQ: INCY) is owned by 99.97% institutional shareholders, 28.53% Incyte insiders, and 0.00% retail investors. Julian Baker is the largest individual Incyte shareholder, owning 19.85M shares representing 9.98% of the company. Julian Baker's Incyte shares are currently valued at $2.01B.

If you're new to stock investing, here's how to buy Incyte stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.